Recently published work suggested that the enzymatic function of PSMA is cleaving glutamate, thereby activating the glutamate-driven phosphoinositide 3-kinase and subsequently the mTOR pathway, leading to tumor cell survival and growth [25,26]. Here, FOLH1 is linked to neoplasm.